Does Botulinum Toxin Type A Interact with Curare Like Agents?
CDI records a moderate classification for Botulinum Toxin Type A and Curare Like Agents. The stored summary is: May potentiate JEUVEAU's neuromuscular blocking effects. Close observation recommended. The mechanism involves interference with neuromuscular transmission. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Botulinum Toxin Type A Class
- Acetylcholine Release Inhibitor
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Interference with neuromuscular transmission
What To Tell Your Doctor or Pharmacist
If you are taking Botulinum Toxin Type A and your doctor is considering prescribing Curare Like Agents (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider